VISICORT consortium meets on November 27, 2020

VISICORT partners met on Friday, November 27, 2020, for an online plenary meeting. All work packages were presented and plans were drawn up on what needs to occur in the remaining 4 months of the project. Major discussion points focussed on biomarker and immunological findings, the follow-up data collection for the prospective and clinical variable studies, final reporting, the status of the VISICORT biobank, the clinical trial and cell product development, and the progress with the EPIMINUE collaboration.